Indivior

Company

Investment-firm

Last deal

Amount

Post-IPO Equity

Stage

12.07.2024

Date

1

all rounds

General

About Company
The world leader in addiction treatment with a patient-focused approach.

Industry

Sector :

Subsector :

Keywords :

founded date

01.01.2014

Number of employees

Company Type

For Profit

Last funding type

Post-IPO Equity

IPO status

Private

Description

With 20 years of experience, this company started with a focus on understanding the journey of individuals suffering from addiction. They aim to transform addiction from a global human crisis to a recognized and treated chronic disease. Indivior is a global pharmaceutical company that develops medicines to treat substance use disorder and serious mental illnesses. They have a pipeline of product candidates designed to expand their heritage in this category and potentially address other chronic conditions and co-occurring disorders of addiction. Indivior has a portfolio of products available in over 40 countries worldwide and employs more than 800 individuals globally. Their guiding principles foster a corporate culture of trust, innovation, and a pioneering spirit.
Contacts